Remove Clinical Trials Remove Drug Trials Remove Marketing
article thumbnail

How using AI in clinical trials accelerates drug development

Pharmaceutical Technology

But before pharmaceutical companies can go to market with a breakthrough drug, they need to ensure safety and efficacy through clinical trials. Pharma R&D teams are solving this problem by leveraging the power of artificial intelligence (AI) in clinical trials to save time and money.

article thumbnail

Reimagining Clinical Trials: Why are Virtual Clinical Trials Becoming the New Normal?

Delveinsight

Clinical trials are an essential part of the drug development process. Worldwide, more than 2 million clinical trials are registered and the number is steadily increasing over the past several years. The conduct of trials was not possible due to the risk of catching coronavirus. Why the Need?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Small Pharma stock market launch funds DMT-based depression drug trial

pharmaphorum

Proceeds from the fundraiser will go towards the phase 1/2a clinical trial the company began in February this year of the lead candidate codenamed SPL026. The goal of the trial is for proof of concept of the drug as a wrap-around therapy for Major Depressive Disorder.

article thumbnail

Leading clinical packaging companies in contract marketing

Pharmaceutical Technology

Unlike commercial pharmaceutical packaging, the primary consideration in clinical trial packaging is protecting the product quality and reliability for research. Finding the best clinical trial packaging services providers. Clinical trial packaging and labelling solutions.

Packaging 100
article thumbnail

STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices

STAT News

And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies. To date, 11 of the 25 private equity firms identified by industry tracker PitchBook as the top investors in health care have bought stakes in clinical research companies.

article thumbnail

Top Three Reasons Why Your Medical Device Needs a Clinical Trial

Advarra

While drugs require Phase I-III clinical trials—and are also subject to post-approval tracking—digital therapeutics, devices, and IVDs may be able to leverage bench testing, animal studies, pilot studies, and training sets. Some markets – specifically the EU – may require publication to obtain product approval.

article thumbnail

Counterfeit Drugs in Clinical Trials?

Placebo Control

This morning I ran across a bit of a coffee-spitter : in the middle of an otherwise opaquely underinformative press release fromTranscelerate Biopharma about the launch of their Counterfeits flooding the market? Or an attempt at depicting the trials of non-Transcelerate members as risky and prone to fraud? Emphasis added.]